National Health Investors, Inc.

Fundamentals7.0
Price Action7.0
News Sentiment7.0
AI Rating
6.0

Key Drivers

  • Very high margins
  • >100% payout
  • Low cash buffer

AI
AI Summary

6.0

NHI's material pivot from passive triple‑net rents to operator‑run SHOPs shifts the investment thesis toward execution‑driven NOI/FFO upside funded by strong reported FCF, but it materially increases operator‑concentration and legal leverage risk (notably the NHC dispute) that could quickly reverse the premium valuation. Monitor three specific triggers before upgrading: (1) sustained SHOP NOI and margin preservation as SHOPs scale toward the 20% NOI target, (2) a clear resolution or mitigation of the NHC master‑lease issue, and (3) recurring FCF coverage of the dividend (FCF/share ≥ dividend) without reliance on one‑offs or dilution.

SHOPPivot
NHCDispute
DividendSustainability‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • Very high margins
  • >100% payout
  • Low cash buffer

NHI delivers exceptional margins and free cash flow supporting a 4.0% yield, but a >100% payout ratio, minimal cash, moderate debt, and rich multiples versus modest ROE/ROA raise sustainability and valuation concerns.

CashFlow
HighPayout

Price Behavior

7.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Broken support
  • Oversold momentum
  • Resistance cluster

NHI is in a short-term downtrend after breaking low-$84 support and closing meaningfully below the last month average near $86.10, testing a new short-term low around $81.90 and facing resistance in the $88–$90 area.

bearish
watch
Support Level: $81.90–$84.00
Resistance Level: $88.00–$90.00

Closed well below last month average (~$86.10) and hit a new short-term low near $81.90

Sentiment & News

7.0

Key News Insights:

  • Beat guidance
  • FFO slight miss
  • Inst. stake up

National Health Investors beat its 2025 guidance and announced a Q1 dividend while reporting Q4 FFO that slightly missed consensus amid board addition and increased institutional buying.

Outperformance
Dividend

Overall results and shareholder activity should underpin investor confidence and support the stock, though the modest FFO miss could limit near-term upside